Our medical and scientific advisors

Our medical and scientific advisors offer expert guidance to the Chief Executive Officer and Board and of Trustees on shaping the charity’s research strategy and grant programme, selecting external peer reviewers, and evaluating applications. They also assist in reviewing research proposals, making funding recommendations, and disseminating the results of funded projects.

We extend our heartfelt thanks to our medical and scientific advisers, who contribute their expertise to develop reliable and comprehensive patient information and provide guidance on the research projects we support. Their dedication and willingness to volunteer their time are deeply appreciated, and we are incredibly grateful for their invaluable assistance.

Patient Information Medical Advisors

Dr Bristi Basu – Consultant Medical Oncologist and Academic Consultant in Experimental Cancer Therapeutics Cambridge University NHS Trust (oncology).

Mr Ross Carter – Glasgow Royal Infirmary (surgical).

Dr Seb Cummins – Royal Surrey County Hospital, Guildford (clinical oncology).

Mr Giuseppe Kito Fusai – University College London Medical School, Royal Free Hospital London(surgical).

Mr Hemant Kocher – Barts and the London Hospital (surgical).

Mr Neville Menezes – Royal Surrey County Hospital, Guildford (surgical).

Mary Phillips – Royal Surrey County Hospital (Hepato-pancreatico-biliary Specialist Dietitian).

Dr Sheela Rao – The Royal Marsden NHS Foundation Trust (medical oncology).

Dr Kevin Shotliff – Chelsea & Westminster Hospital & Brompton Hospital. Royal Marsden Hospital (endocrinology).

Clinical Research – Scientific Advisory Committee

The Pancreatic Cancer Action Scientific Advisory Committee (SAC) was established to advise the Board of Trustees and Chief Executive on research strategies and funding policies. The SAC provides recommendations for changes and improvements where necessary. It ensures independent reviews of research grant proposals and advises the trustees on the allocation of research funds. Additionally, the SAC oversees the processes for monitoring and reporting on funded research activities in a timely manner.

The SAC is to provide independent scientific advice to PCA’s Board of Trustees and Chief Executive on the following areas:

• Develop and maintain an overview of pancreatic cancer research being undertaken worldwide, and to identify and make recommendations on the most appropriate areas for research investment by the Charity, either alone or in partnership with other organisations and in line with PCA’s Charitable Objects.
  
  
• Whether to fund specific research proposals and provide recommendations on individual grant applications in a timely fashion, so that grant round deadlines can be met.
  
  
• To make recommendations on the establishment of effective processes for inviting (and making decisions on) high quality research applications.
  
  
• Help identify and recruit external peer reviewers to undertake evaluations of individual research applications where applicable.
  
  
• To ensure clear, measurable outcomes such as evidence of project planning and budgeting, form part of the grant awarding process.
  
  
• Ensuring that all research is conducted to the highest ethical standards, complies with all relevant regulations and guidelines, and is conducted in an environment which supports the highest standards of research governance.